Delivery Order SPE2DR25D9211-SPE2DR26FCAWA
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,113.54 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The delivery order, issued on December 6, 2025, with an ultimate completion date of December 29, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite...
- The Defense Logistics Agency awarded a $1,113.52 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The delivery order, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, carries no set-aside designation, indicating the award was made through unrestricted federal procurement. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. The delivery order, issued on November 10, 2025, with an ultimate completion date of December 3, 2025, carries firm fixed-price terms and received no set-aside designation, demonstrating the contractor's competitive capability in unrestricted...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,670.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order, issued on December 4, 2025, with an ultimate completion date of December 26, 2025, was awarded without a set-aside designation, demonstrating DMS Pharmaceutical Group's competitive capability in unrestricted...
- The Defense Logistics Agency awarded a $1,113.52 delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vial format. The contract, issued on November 25, 2025, with an ultimate completion date of December 17, 2025, utilizes firm fixed-price pricing with no set-aside designation, allowing the vendor to compete on an unrestricted basis. This delivery order is...
- The Defense Logistics Agency awarded a $1,113.52 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of YF-VAX (yellow fever vaccine) in single-dose vials. The delivery order, issued on November 18, 2025, with an ultimate completion date of December 10, 2025, carries no set-aside designation, indicating the award was made on a competitive basis. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,670.28 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in single-dose vials. This firm fixed-price delivery order, issued on November 6, 2025, with an ultimate completion date of December 1, 2025, carries no set-aside designation, indicating the vendor competed in unrestricted federal procurement. The award represents one...
- The Defense Logistics Agency awarded a $1,113.52 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) vials. The delivery order, issued on December 1, 2025, with an ultimate completion date of December 22, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award is issued under DMS...
- The Defense Logistics Agency awarded a $1,670.28 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order, issued on November 24, 2025, with an ultimate completion date of December 16, 2025, carries no set-aside designation, indicating the award was made through open competition. This delivery order is issued under DMS...
- The Defense Logistics Agency awarded a $22,270.40 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) in one-dose vial format. The delivery order, issued on December 11, 2025, with an ultimate completion date of January 5, 2026, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement....
- SPE2DR25D9211Indefinite Delivery Contract
- SPE2DR25D9211-SPE2DR26FCAWADelivery Order
The Defense Logistics Agency awarded a $1,113.52 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for YF-VAX (yellow fever vaccine) one-dose vials. The delivery order, issued December 1, 2025, with an ultimate completion date of December 22, 2025, carries no set-aside designation, indicating the award was made through open competition. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) designated SPE2DR, which was established under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative on November 13, 2025, with a $499.999 billion ceiling value extending through December 31, 2036. The PPV-G GEN V represents a $30.3 billion acquisition strategy designed to supply the Department of Defense's medical logistics needs globally. As one of multiple regional prime vendor contractors under this program, DMS Pharmaceutical Group is authorized to fulfill diverse pharmaceutical requirements for military healthcare facilities worldwide, including branded and generic prescription drugs, biologics, vaccines, and medical consumables. The company's established performance across numerous delivery orders since October 2025 demonstrates its capability to support the specialized pharmaceutical supply chain needs of the federal military medical system across multiple therapeutic categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 11/30/25 |